"I should be one of the enthusiastic ones, but in reality, I'm one of the skeptics, or cautious at least," says Riccardo De Giorgi, psychiatrist and clinical researcher who studies mental health and GLP-1s at the University of Oxford
WEGOVY (semaglutide) injection, for subcutaneous use
As more employers bring SmartRx to their people, we expect the impact to scale significantly by reducing drug costs and building the clinical foundation that makes savings and outcomes stick
People who have conditions like endocrine neoplasia syndrome type 2 or gallbladder disease need close monitoring during treatment
See what the 10-year data suggests) While GLP-1 medications can have a number of potential side effects, it is important to note that these medications are generally considered safe and effective for the treatment of type 2 diabetes and for weight loss
References Bankhead, C